Financhill
Sell
14

KROS Quote, Financials, Valuation and Earnings

Last price:
$16.07
Seasonality move :
10.52%
Day range:
$15.82 - $16.70
52-week range:
$15.33 - $73.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
852.94x
P/B ratio:
1.21x
Volume:
523.5K
Avg. volume:
1.4M
1-year change:
-63.09%
Market cap:
$644.9M
Revenue:
$151K
EPS (TTM):
-$5.21

Earnings Data

Next earnings date for KROS
Feb 28
2025
Most recent earnings per share
-$1.41
Missed by $0.13
(Nov 6/2024)
Consensus Estimate
-$1.28
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KROS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $22.2M -- -- -$1.37 --
02/28/2025 Q4 $34.2M -- -- -$0.51 --
11/06/2024 Q3 -- $388K -$1.41 -$1.28 -$0.13
08/07/2024 Q2 -- $37K -$1.25 -$1.25 $0.00
05/08/2024 Q1 -- $83K -$1.21 -$1.33 $0.12
02/28/2024 Q4 -- $143K -$1.34 -$1.39 $0.05
11/06/2023 Q3 -- -- -$1.33 -$1.35 $0.02
08/07/2023 Q2 -- -- -$1.27 -$1.35 $0.08
05/04/2023 Q1 -- -- -$1.26 -$1.14 -$0.12
03/03/2023 Q4 -- -- -$1.09 -$1.10 $0.01
11/03/2022 Q3 -- -- -$0.92 -- --
08/04/2022 Q2 -- -- -$1.13 -- --
05/05/2022 Q1 -- -- -$1.01 -- --
03/09/2022 Q4 -- -- -$0.30 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- -- -$0.67 -- --
05/06/2021 Q1 -- -- -$0.68 -- --
03/25/2021 Q4 -- -- -$0.49 -- --
11/10/2020 Q3 -- -- -$0.60 -- --
08/13/2020 Q2 -- -- -$0.62 -- --
05/22/2020 Q1 -- -- -$0.70 -- --
12/31/2019 Q4 -- -- -$0.18 -- --
09/30/2019 Q3 -- -- -$0.45 -- --
06/30/2019 Q2 -- -- -$0.37 -- --
03/31/2019 Q1 -- -- -$0.41 -- --

Keros Therapeutics Earnings Questions

  • How Much did Keros Therapeutics Generate in Revenue Last Quarter?

    Keros Therapeutics reported $388K worth of top line sales in its most recent quarter.

  • Did Keros Therapeutics Beat Earnings Last Quarter?

    Keros Therapeutics announced earnings per share of -$1.41 which represents a miss of analyst forecast a -$1.28 per share.

  • Is Keros Therapeutics Profitable?

    Keros Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Keros Therapeutics EPS Next Year?

    Keros Therapeutics's earnings are forecast to decrease from -$5.20 per share to -$4.22 per share next year representing a decrease of -3%.

  • When is Keros Therapeutics's Earnings Date?

    Keros Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Carlos Slim Buy PBF Energy?
Why Did Carlos Slim Buy PBF Energy?

Carlos Slim made a splash in a surprising sector last…

Is Booking Holdings Stock Undervalued?
Is Booking Holdings Stock Undervalued?

There is a lot of humdrum in the market about…

Broadcom vs American Express: Which Is Best?
Broadcom vs American Express: Which Is Best?

Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
47
DRUG alert for Jan 3

Bright Minds Biosciences [DRUG] is down 4.28% over the past day.

Buy
88
BMA alert for Jan 3

Banco Macro SA [BMA] is up 0.88% over the past day.

Sell
50
AGFY alert for Jan 3

Agrify [AGFY] is down 5.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock